PanGen Biotech Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PanGen Biotech Inc

Watchlist Manager

Watchlist

Price: 5 070 KRW -1.93% Market Closed

Market Cap: ₩68.5B

P	PanGen Biotech Inc KOSDAQ:222110	KR
	Brand Architekts Group PLC LSE:BAR	UK
A	Attika Group Ltd SGX:53W	SG
S	SoulBrain Co Ltd KOSDAQ:357780	KR

Profitability Summary

PanGen Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

32%

Sustainable 3Y Average Gross Margin

33%

Gross Margin is Increasing

5% > 32%

Low Operating Margin

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-111% > 9%

Healthy Net Margin

15%

Negative 3Y Average Net Margin

-4%

Net Margin is Increasing

-108% > 15%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

-107% > -6%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.